Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7-day preoperative letrozole effect on Ki67 in hormone receptor-positive early breast cancer
IRCT20101104005101N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of letrozole in breast cancer, sponsored by Tehran University of Medical Sciences. Primary endpoint: Cell proliferation factor (Ki67%) level. Started Feb 2020; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20101104005101N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101104005101N2.